YungShin Global Holding Corporation
Research YungShin Global Holding Corporation (3705.TW) on Bullrun: market cap TWD 16.51B, P/E 18.5, dividend yield 5.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3705.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 16.51B
- P/E18.5
- Dividend yield5.2%
- Financial periodQ2 2026
- RevenueTWD 1.93B
- Net incomeTWD 197.46M
- Free cash flowTWD 191.24M
- Gross margin44.6%
Valuation Snapshot
latest market cap is TWD 16.51B; P/E is 18.5; dividend yield is 5.2%.
Peer valuation comparison
Latest P/E is 18.45x versus a Healthcare sector median of 21.8x (15.3% below).
Latest dividend yield is 5.16% versus a Healthcare sector median of 2.4% (115.0% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 16.51B | 18.5 | 4.8% | 3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3 TWD, yield 5.2%.
About YungShin Global Holding Corporation
YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.
ETFs that hold YungShin Global Holding Corporation
US-listed ETFs
YungShin Global Holding Corporation is held by 20 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is YungShin Global Holding Corporation's market cap?
YungShin Global Holding Corporation's market capitalization is TWD 16.51B.
What is YungShin Global Holding Corporation's P/E ratio?
YungShin Global Holding Corporation's price-to-earnings (P/E) ratio is 18.5.
Does YungShin Global Holding Corporation pay a dividend?
YungShin Global Holding Corporation has a dividend yield of 5.2%.
What does YungShin Global Holding Corporation do?
YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.